Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Single Arm Study to Evaluate the Immunological Efficacy and Safety of GC3110A. Administered Intramuscularly in Healthy Subjects Aged 65 Years and Older

NCT02917304 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT02917304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02917304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Single Arm Study to Evaluate the Immunological Efficacy and Safety of GC3110A. Administered Intramuscularly in Healthy Subjects Aged 65 Years and Older
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Completed
Start date
October 10, 2016
Completion date
May 8, 2017
Enrollment
274 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, human